<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0"><channel><title>Healthcare Sidley Updates</title><link>https://www.sidley.com/ja/rss/healthcare-sidley-updates</link><description /><language>ja</language><ttl>60</ttl><item><guid isPermaLink="false">{AA1A85DF-D46D-4AA2-86E5-3A6B34E51B78}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2026/04/most-favored-nation-drug-pricing-policy-executive-actions-manufacturer-agreements</link><category>Sidley Updates</category><title>Most-Favored-Nation Drug Pricing Policy: Executive Actions, Manufacturer Agreements, and Growing Congressional Scrutiny</title><description /><pubDate>Wed, 22 Apr 2026 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{012B7DD6-9CE4-4C25-9BF7-C5C156F32FA4}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2026/04/white-house-and-doj-announce-sweeping-new-anti-fraud-initiatives</link><category>Sidley Updates</category><title>White House and DOJ Announce Sweeping New Anti-Fraud Initiatives</title><description /><pubDate>Fri, 10 Apr 2026 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{DA5468F3-BA87-44F6-BB29-6C79D1EFBECB}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2026/03/market-access-another-favorable-medical-products-advisory-opinion-from-hhs</link><category>Sidley Updates</category><title>#Market Access: Another Favorable Medical Products Advisory Opinion from HHS-OIG Signals New Flexibilities</title><description /><pubDate>Thu, 19 Mar 2026 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{8C1D1E4D-0730-4A50-99CE-E8F6CDFDC63B}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2026/03/new-us-doj-antitrust-leadership-signals-more-criminal-prosecutions-and-longer-prison-sentences</link><category>Sidley Updates</category><title>New U.S. DOJ Antitrust Leadership Signals More Criminal Prosecutions and Longer Prison Sentences</title><description /><pubDate>Fri, 06 Mar 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{F0C3CAF2-12DD-4867-AAFE-0690BBE93F28}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2026/02/direct-to-consumer-prescription-drug-platforms-new-government-guidance-and-comment-opportunity</link><category>Sidley Updates</category><title>Direct-to-Consumer Prescription Drug Platforms: New Government Guidance and Comment Opportunity</title><description /><pubDate>Tue, 24 Feb 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{921CA9D9-9ABB-490B-8F6B-5264836A66D2}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2026/02/congress-passes-significant-federal-pharmacy-benefit-manager-reform-impacting-pharmaceutical-market</link><category>Sidley Updates</category><title>Congress Passes Significant Federal Pharmacy Benefit Manager Reform Impacting Pharmaceutical Market Access</title><description /><pubDate>Wed, 18 Feb 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{41E7055D-B7A1-4411-856C-CCB7D4ED4406}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2026/02/oig-releases-long-awaited-medicare-advantage-compliance-program-guidance</link><category>Sidley Updates</category><title>OIG Releases Long-Awaited Medicare Advantage Compliance Program Guidance</title><description /><pubDate>Tue, 10 Feb 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{4FD37680-D6A6-4C4E-87FB-0EB723B27090}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2026/01/medical-products-market-access-favorable-advisory-opinion-reaffirms-discounting-flexibilities</link><category>Sidley Updates</category><title>Medical Products Market Access: Favorable Advisory Opinion Reaffirms Discounting Flexibilities</title><description /><pubDate>Wed, 21 Jan 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{98235C28-1F65-4421-A2DB-3CB95D7832A0}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2026/01/top-10-areas-we-watching-for-2026</link><category>Sidley Updates</category><title>Top 10 FDA Areas We Are Watching For 2026</title><description>As 2026 begins, there is much to look forward to as companies and investors in the life sciences and medtech industries navigate a profoundly changing regulatory environment at FDA. With 2025 witnessing generational changes at FDA, we’re keeping an eye on opportunities and challenges for the year to come.</description><pubDate>Mon, 12 Jan 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{490F99D9-E289-43C4-A7D5-4630D04D2251}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2026/01/drugpricing-more-average-sales-price-proposals-and-new-comment-period</link><category>Sidley Updates</category><title>#DrugPricing: More Average Sales Price Proposals and New Comment Period</title><description /><pubDate>Tue, 06 Jan 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{B7654E8E-8185-416F-86FD-76BFE038E8E4}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/12/biosecure-act-included-in-the-fy2026-national-defense-authorization-act</link><category>Sidley Updates</category><title>BIOSECURE Act Included in the FY2026 National Defense Authorization Act</title><description /><pubDate>Fri, 12 Dec 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{D92DA836-023B-4C42-B155-43A76622D984}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/12/us-drug-pricing-year-in-review-reflections-on-2025-and-getting-ready-for-2026</link><category>Sidley Updates</category><title>U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026</title><description /><pubDate>Thu, 11 Dec 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{80BB087E-FE40-4CAB-969D-7F1F33BA4490}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/12/what-the-us-uk-drug-pricing-agreement-reveals-about-how-mfn-drug-policy-could-impact-the-uk-and-eu</link><category>Sidley Updates</category><title>What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EU</title><description /><pubDate>Wed, 10 Dec 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{1FDB0166-E339-4D75-8C0B-6785F877CC64}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/12/medicare-payment-policy-final-rule-for-outpatient-setting-addresses-radiopharmaceuticals</link><category>Sidley Updates</category><title>Medicare Payment Policy Final Rule for Outpatient Setting Addresses Radiopharmaceuticals, Skin Substitutes, and 340B Program Key Topics</title><description /><pubDate>Tue, 02 Dec 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{475B293B-BC7A-4153-B69C-75EB1917ABED}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/11/us-fda-and-cms-actions-on-generative-ai-enabled-mental-health-devices-yield-insights-across-ai</link><category>Sidley Updates</category><title>U.S. FDA and CMS Actions on Generative AI-Enabled Mental Health Devices Yield Insights Across AI Product Development</title><description /><pubDate>Wed, 12 Nov 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{8A344660-AAA7-495D-9E49-06F7060CE33D}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/11/cms-announces-voluntary-most-favored-nation-pricing-in-medicaid-through-the-generous-model</link><category>Sidley Updates</category><title>CMS Announces Voluntary Most-Favored-Nation Pricing in Medicaid Through the GENEROUS Model</title><description /><pubDate>Tue, 11 Nov 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{44C55643-195A-43D1-BB34-E39A63E31A15}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/11/cms-finalizes-key-medicare-reimbursement-policies-for-telehealth-chronic-disease-and-digital-health</link><category>Sidley Updates</category><title>CMS Finalizes Key Medicare Reimbursement Policies for Telehealth, Chronic Disease, and Digital Health</title><description /><pubDate>Tue, 04 Nov 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{00A929E4-7CF6-4098-9C1B-9EF1F16E4FC7}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/10/major-changes-to-us-government-pricing-requirements-finalized-with-some-wins-for-pharma-and-biotech</link><category>Sidley Updates</category><title>Major Changes to U.S. Government Pricing Requirements Finalized, With Some Wins for Pharma and Biotech</title><description /><pubDate>Mon, 03 Nov 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{19637343-5B32-4BB5-B697-0CE992600807}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/10/california-adds-second-law-in-one-week-targeting-healthcare-investments</link><category>Sidley Updates</category><title>California Adds Second Law in One Week Targeting Healthcare Investments</title><description /><pubDate>Tue, 14 Oct 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{B388160D-BB8A-4DE5-8EC9-D5A749A68BBC}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/10/inflation-reduction-act-cms-publishes-final-guidance-for-initial-price-applicability-year-2028</link><category>Sidley Updates</category><title>Inflation Reduction Act: CMS Publishes Final Guidance for Initial Price Applicability Year 2028</title><description /><pubDate>Thu, 09 Oct 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{88576A72-1092-4C80-A0CC-37B58E53CBF6}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/10/newly-enacted-california-law-formalizes-corporate-practice-restrictions</link><category>Sidley Updates</category><title>Newly Enacted California Law Formalizes Corporate Practice Restrictions</title><description /><pubDate>Wed, 08 Oct 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{D60F0B1E-D844-48AC-A0B8-191BA20F155C}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/09/sec-grants-no-action-relief-for-retail-voting-program</link><category>Sidley Updates</category><title>SEC Grants No-Action Relief for Retail Voting Program</title><description /><pubDate>Wed, 17 Sep 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{BF0282C1-A3F0-44DF-8C88-39CF1DD3B08C}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/09/rare-disease-and-specialty-product-manufacturers-distribution-model-considerations</link><category>Sidley Updates</category><title>Rare Disease and Specialty Product Manufacturers: Distribution Model Considerations</title><description /><pubDate>Tue, 16 Sep 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{DF68F06A-2D8F-4A9C-B350-D14FCF017593}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/08/new-digital-health-ecosystem-and-hipaa-flexibilities-facilitate-sharing-of-patient</link><category>Sidley Updates</category><title>New Digital Health Ecosystem and HIPAA Flexibilities Facilitate Sharing of Patient Health Information</title><description /><pubDate>Fri, 29 Aug 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{8D80D31F-A141-4B90-BD75-9220EF5C1C43}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/08/physician-owned-medical-device-arrangement-approved-by-hhs-oig</link><category>Sidley Updates</category><title>Physician-Owned Medical Device Arrangement Approved by HHS-OIG</title><description /><pubDate>Wed, 20 Aug 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{D38838EF-BA7C-4331-860B-F3BE13CEC17A}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/07/lab-compliance-companion-diagnostic-testing-arrangement-approved-by-hhs</link><category>Sidley Updates</category><title>Lab Compliance: Companion Diagnostic Testing Arrangement Approved by HHS Office of Inspector General</title><description /><pubDate>Thu, 24 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{6D41037F-641F-4DC2-A995-0E34D1E7180D}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/07/key-medicare-reimbursement-policies-under-the-microscope-in-proposed-rule</link><category>Sidley Updates</category><title>Key Medicare Reimbursement Policies Under the Microscope in Proposed Rule</title><description /><pubDate>Thu, 24 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{95EC37FE-BF02-459B-A937-CE5E8F7195C4}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/07/big-changes-and-big-opportunities-navigating-the-employee-benefits-provisions-of-the-obbb-act</link><category>Sidley Updates</category><title>Big Changes and Big Opportunities: Navigating the Employee Benefits Provisions of the One Big Beautiful Bill Act</title><description /><pubDate>Wed, 23 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{D691DE81-A1E2-4913-ABD3-2AE86BBD9BF3}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/07/early-stage-life-sciences-partnerships-raise-later-stage-considerations</link><category>Sidley Updates</category><title>Early-Stage Life Sciences Partnerships Raise Later-Stage Considerations</title><description /><pubDate>Mon, 21 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{47167045-1268-4DB1-8F1E-A944DE3A6FCE}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/07/major-us-government-price-reporting-proposals-warrant-industry-comment</link><category>Sidley Updates</category><title>Major U.S. Government Price Reporting Proposals Warrant Industry Comment</title><description /><pubDate>Fri, 18 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{5FE9AB0C-0DEB-467B-90E4-858598D55F69}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/07/us-ftc-click-to-cancel-rule-struck-down</link><category>Sidley Updates</category><title>U.S. FTC Click-to-Cancel Rule Struck Down</title><description /><pubDate>Thu, 17 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{3A941B0D-581A-443F-9F7A-255DD9C318C6}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/07/key-inflation-reduction-act-amendment-broadens-us-protection-for-orphan-drugs</link><category>Sidley Updates</category><title>Key Inflation Reduction Act Amendment Broadens U.S. Protection for Orphan Drugs</title><description /><pubDate>Tue, 15 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{A7B865B3-8373-49CE-A5C7-238ED45F6A1C}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/07/whistleblower-rewards-continue-to-grow-us-dojs-antitrust-division-joins-the-fray</link><category>Sidley Updates</category><title>Whistleblower Rewards Continue to Grow: U.S. DOJ’s Antitrust Division Joins the Fray</title><description /><pubDate>Wed, 09 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{42014500-010E-4F5F-9B1E-E831C49B3770}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/07/us-doj-announces-renewal-of-fca-working-group</link><category>Sidley Updates</category><title>U.S. DOJ Announces Renewal of FCA Working Group</title><description /><pubDate>Mon, 07 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{B74B9AC0-0EE8-4535-BA68-D56B80F05B2B}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/06/eu-limits-chinese-participation-in-medical-devices-procurement</link><category>Sidley Updates</category><title>EU Limits Chinese Participation in Medical Devices Procurement</title><description /><pubDate>Mon, 30 Jun 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{63F34AF7-75A9-47CA-A65A-0E60CDF2179C}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/06/us-doj-civil-division-to-investigate-possible-violations-of-the-fdca-by-pharmaceutical-companies</link><category>Sidley Updates</category><title>U.S. DOJ Civil Division to Investigate Possible Violations of the Food, Drug, and Cosmetic Act by Pharmaceutical Firms Manufacturing Drugs Used in Gender Transition Care</title><description /><pubDate>Mon, 23 Jun 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{967F4A66-66EB-4B97-B7FF-18BA6D3CDAA5}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/05/us-cms-sets-stage-for-2028-medicare-drug-price-negotiations</link><category>Sidley Updates</category><title>CMS Sets Stage for 2028 Medicare Drug Price Negotiations — First Look at Negotiations for Part B</title><description /><pubDate>Wed, 21 May 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{9156F783-236E-4EE7-A4DB-AC1D3DCA0390}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/05/most-favored-nation-drug-pricing-executive-order-signals-potential-us-major-policy-shift</link><category>Sidley Updates</category><title>Most-Favored-Nation Drug Pricing: Executive Order Sets Forth Potential U.S. Major Policy Shift</title><description /><pubDate>Thu, 15 May 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{E15D1216-BEB2-4DCD-ABDE-C6D92A5573BB}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/05/medicare-reimbursement-pathway-for-ai-enabled-medical-devices-considered</link><category>Sidley Updates</category><title>Medicare Reimbursement Pathway for AI-Enabled Medical Devices Considered in Senate’s Health Tech Investment Act</title><description /><pubDate>Tue, 13 May 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{0CE561FA-DACE-46A9-BE99-3A485C08AFEE}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/05/laboratory-compliance-the-latest-case-developments-on-commission-payments</link><category>Sidley Updates</category><title>Laboratory Compliance: The Latest Case Developments on Commission Payments</title><description /><pubDate>Thu, 08 May 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{08F09501-9AAA-43CC-B0EB-6A6E039B4A7B}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/05/aaa-revises-consumer-and-employment-workplace-arbitration-rules</link><category>Sidley Updates</category><title>AAA Revises Consumer and Employment/Workplace Arbitration Rules</title><description /><pubDate>Thu, 08 May 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{04C0D967-F7F5-4948-8937-4B1F9554D00F}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/05/us-fda-plans-to-increase-the-number-of-surprise-foreign-inspections</link><category>Sidley Updates</category><title>U.S. FDA Plans to Increase the Number of Surprise Foreign Inspections</title><description /><pubDate>Wed, 07 May 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{2AE68683-F756-4F18-BF85-C38B7724D7C7}</guid><link>https://www.sidley.com/ja/insights/newsupdates/2025/05/federal-court-clarifies-medicaid-rebate-reporting-requirements-for-new-strengths</link><category>Sidley Updates</category><title>Federal Court Clarifies Medicaid Rebate Reporting Requirements for New Strengths</title><description /><pubDate>Wed, 07 May 2025 05:00:00 Z</pubDate></item></channel></rss>